• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Castle Biosciences, Inc. - Common stock (NQ:CSTL)

28.00 +1.21 (+4.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Castle Biosciences, Inc. - Common stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
Dow Drops Triple Digits; S&P 500, Nasdaq Extend Highs ↗
June 05, 2023
Via Talk Markets
News headline image
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
June 05, 2023
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
June 05, 2023
  Monday's session saw 41 companies set new 52-week lows. 
Via Benzinga
News headline image
Why Shares of Castle Biosciences Slumped This Week ↗
June 02, 2023
Investors were unimpressed by the company's study regarding its IDgenetix test. 
Via The Motley Fool
News headline image
Nasdaq Rises 70 Points; ISM Services PMI Drops In May ↗
June 05, 2023
U.S. stocks traded mixed midway through trading, with Nasdaq Composite gaining around 70 points on Monday. The Dow traded down 0.21% to 33,691.13 while the NASDAQ rose 0.54% to 13,312.65. The S&P 500,... 
Via Benzinga
News headline image
EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday ↗
June 05, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
US Stocks Mixed; SAIC Posts Upbeat Results ↗
June 05, 2023
U.S. stocks traded mixed this morning, with Dow Jones dropping around 20 points on Monday. Following the market opening Monday, the Dow traded down 0.06% to 33,740.98 while the NASDAQ rose 0.08% to... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
June 05, 2023
 
Via Benzinga
News headline image
Looking Into Castle Biosciences's Return On Capital Employed ↗
May 11, 2023
 
Via Benzinga
News headline image
Analyst Expectations for Castle Biosciences's Future ↗
May 04, 2023
 
Via Benzinga
News headline image
Framework Incorporating DecisionDx®-SCC Test Results into Clinical Decision-Making for Patients with High-Risk Cutaneous Squamous Cell Carcinoma Published in Clinical, Cosmetic and Investigational Dermatology
June 05, 2023
From Castle Biosciences Inc.
Via Business Wire
News headline image
Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual Meeting
June 03, 2023
From Castle Biosciences Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
June 01, 2023
 
Via Benzinga
News headline image
Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
June 01, 2023
Gainers Reunion Neuroscience Inc. (NASDAQ: REUN) gained 95% to $1.33 after the company announced a $13.1 million take-private transaction with MPM BioImpact. 
Via Benzinga
News headline image
IDgenetix® Shown to Significantly Improve Medication Response and Remission Rates in Patients with Major Depressive Disorder
May 31, 2023
From Castle Biosciences Inc.
Via Business Wire
News headline image
Castle Biosciences Celebrates Skin Cancer Awareness Month
May 30, 2023
From Castle Biosciences Inc.
Via Business Wire
News headline image
Castle Biosciences’ Abstracts at Digestive Disease Week (DDW) Annual Meeting Selected as “Posters of Distinction” by the American Gastroenterological Association (AGA) Institute Council
May 26, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Castle Biosciences Opens New State-of-the-Art Laboratory in Pittsburgh
May 22, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Castle Biosciences’ TissueCypher® Barrett's Esophagus Test Receives 2023 MedTech Breakthrough Award for Artificial Intelligence Innovation
May 15, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Castle Biosciences Reports First Quarter 2023 Results
May 03, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Study Demonstrates Use of DecisionDx®-Melanoma to Guide Treatment Decisions Resulted in Earlier Detection of Melanoma with Decreased Metastatic Tumor Burden Compared to Patients Without Surveillance Imaging Studies
May 03, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Castle Biosciences Collaborates with IMPACT Melanoma to Provide Free Sunscreen to Cyclists Participating in the Bike MS: Texas MS 150 2023 Cycling Event
April 28, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
DecisionDx®-Melanoma Provides Improved Risk Stratification Over American Joint Committee on Cancer (AJCC) Staging Alone in Stage I Melanoma Patients
April 25, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
TissueCypher® Test Results Can Increase the Likelihood of Appropriate Management Decisions for Barrett’s Esophagus Patients with Low-Grade Dysplasia
April 20, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Castle Biosciences to Release First Quarter 2023 Financial Results and Host Conference Call on Wednesday, May 3
April 19, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Castle Biosciences to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
7 Value Stocks to Buy for Long-Term Growth ↗
March 26, 2023
If you have the patience to ride out some choppy weather, these value stocks to buy may offer significant upside later. 
Via InvestorPlace
News headline image
Late-Breaking Data Presented at the 2023 AAD Annual Meeting Demonstrates Improved Accuracy of DecisionDx®-SCC in Predicting Metastatic Risk Over Traditional Staging Systems in Independent, Multi-Center Cohort Study
March 18, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
March 14, 2023
From Castle Biosciences, Inc.
Via Business Wire
News headline image
Castle Biosciences to Highlight Clinical Value of Its Skin Cancer Tests at the 2023 American Academy of Dermatology (AAD) Annual Meeting
March 10, 2023
From Castle Biosciences, Inc.
Via Business Wire
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap